Prof. Ingemar Ernberg, discusses the differences between EBV research and Coronavirus Research

Prof Dr Ingemar Ernberg, Professor, Department of Microbiology, Tumour and Cell Biology & Chair, Personalised Cancer Medicine (PCM) Programme, of Karolinska Institutet, joined us on February 11 to discuss The Impact of COVID-19 on Cancer Research.

“I know that in the German repository which is made really for influenza virus sequences, I know there are 450,000 coronavirus sequences, and we have 450 of EBV.”

Find out more about our Virtual Panel Series here.

Please feel free to share this...